ESC Professional Premium Access

Differential impact of milvexian, an investigational oral FXIa inhibitor vs apixaban and dabigatran on thrombin generation in human donor plasma in vitro

Congress Presentation

About the speaker

Doctor Madhu Chintala

Janssen R&D, Spring House (United States of America)
1 follower

6 more presentations in this session

Genome-wide association study on cerebral white-matter hyperintensities in 36,577 individuals

Speaker: Mr J. Jespersen (Copenhagen, DK)


DNA damage induced by radiation exposure from cardiac catheterization - an analysis in patients and operators

Speaker: Doctor T. Ishida (Fukushima, JP)


SWATH proteomic analysis from the standard care versus celecoxib outcome trial identifies renal biomarkers are associated with early cardiovascular events amongst NSAID users

Speaker: Doctor R. Vaja (London, GB)


Preservation of vasculature is beneficial in mitigating cisplatin induced acute kidney injury

Speaker: Associate Professor H. Pan (Saint Louis, US)


Lack of PI 3-kinase isoform p110alpha impairs SMC differentiation and proliferation and promotes aortic aneurysm formation

Speaker: Doctor M. Vantler (Cologne, DE)


Access the full session

Clinical and basic science insights in vascular disease

Speakers: Doctor M. Chintala, Mr J. Jespersen, Doctor T. Ishida, Doctor R. Vaja, Associate Professor H. Pan...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb